#FedMinutesShowNoSupportForRateCuts
$HYPE Perp $BTW Perp
India has seen 80 billion USD of Inflows via her subsidized SWAP Window by stimulating the FCNR Deposits.
Ultragenyxs Gene therapy --- molecule --- Genglycose --- Phosphopyranose Peptide has got FDA approval ---- in the treatment of blood sugar management.
The blood sugar controlling agent is yet to be decided as an active agent for long acting or short acting therapeutic group.
FDA has aporoved the molecule as an synergystic therapeutic agent for blood sugar reduction & Liver Glycogen Storage depletion Stimulant.
Market Senario ----
Dowjones --- Positive Nikkei ---- Positive
Intermarket --- Variable Slope Volatility With Bridging Expected ---- Exchange Balance Volatility Expected
$HYPE Perp $BTW Perp
India has seen 80 billion USD of Inflows via her subsidized SWAP Window by stimulating the FCNR Deposits.
Ultragenyxs Gene therapy --- molecule --- Genglycose --- Phosphopyranose Peptide has got FDA approval ---- in the treatment of blood sugar management.
The blood sugar controlling agent is yet to be decided as an active agent for long acting or short acting therapeutic group.
FDA has aporoved the molecule as an synergystic therapeutic agent for blood sugar reduction & Liver Glycogen Storage depletion Stimulant.
Market Senario ----
Dowjones --- Positive Nikkei ---- Positive
Intermarket --- Variable Slope Volatility With Bridging Expected ---- Exchange Balance Volatility Expected